Common Contracts
3 similar Letter Agreement contracts by Mineralys Therapeutics, Inc.
Re: Amended and Restated Employment LetterLetter Agreement • February 2nd, 2023 • Mineralys Therapeutics, Inc. • Pharmaceutical preparations • Colorado
This amended and restated employment letter agreement (this “Agreement”) amends and restates that certain employment letter agreement (the “Prior Agreement”), dated March 8, 2022, between you and Mineralys Therapeutics, Inc. (the “Company”). This Agreement sets forth the terms of your continued employment with the Company, effective as of the date on which the registration statement on Form S-1 filed in connection with the Company’s initial public offering (“IPO”) becomes effective. In consideration of the mutual promises herein contained, the parties agree as follows:
Re: Amended and Restated Employment LetterLetter Agreement • February 2nd, 2023 • Mineralys Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts
This amended and restated employment letter agreement (this “Agreement”) amends and restates that certain employment letter agreement (the “Prior Agreement”), dated January 8, 2021, between you and Mineralys Therapeutics, Inc. (the “Company”). This Agreement sets forth the terms of your continued employment with the Company, effective as of the date on which the registration statement on Form S-1 filed in connection with the Company’s initial public offering (“IPO”) becomes effective. In consideration of the mutual promises herein contained, the parties agree as follows:
Re: Amended and Restated Employment LetterLetter Agreement • February 2nd, 2023 • Mineralys Therapeutics, Inc. • Pharmaceutical preparations • Pennsylvania
This amended and restated employment letter agreement (this “Agreement”) amends and restates that certain employment letter agreement (the “Prior Agreement”), dated October 9, 2020, between you and Mineralys Therapeutics, Inc. (the “Company”). This Agreement sets forth the terms of your continued employment with the Company, effective as of the date on which the registration statement on Form S-1 filed in connection with the Company’s initial public offering (“IPO”) becomes effective. In consideration of the mutual promises herein contained, the parties agree as follows:
